Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Acta Histochemica

• Publication date

  2018-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.acthis.2018.02.006PMID 29482933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.

  2018cited by this paper
• High fat diet dysregulates microRNA-17-5p and triggers retinal inflammation: Role of endoplasmic-reticulum-stress

  2017cited by this paper
• Deletion of TXNIP Mitigates High-Fat Diet-Impaired Angiogenesis and Prevents Inflammation in a Mouse Model of Critical Limb Ischemia

  2017cited by this paper
• Non-alcoholic fatty liver disease in 2015.

  2015cited by this paper
• Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation

  2015cited by this paper
• Role of Inflammasome Activation in the Pathophysiology of Vascular Diseases of the Neurovascular Unit

  2015cited by this paper
• Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

  2014cited by this paper
• Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools

  2014cited by this paper
• Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet

  2014cited by this paper
• NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice

  2014cited by this paper
• Deletion of thioredoxin‐interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury

  2014cited by this paper
• Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.

  2014cited by this paper
• Thioredoxin-Interacting Protein Expression Is Required for VEGF-Mediated Angiogenic Signal in Endothelial Cells

  2013cited by this paper
• Toll‐like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice

  2013cited by this paper
• Quercetin and allopurinol reduce liver thioredoxin‐interacting protein to alleviate inflammation and lipid accumulation in diabetic rats

  2013cited by this paper
• Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease

  2012cited by this paper
• Inflammasomes in liver diseases.

  2012cited by this paper
• Thioredoxin Interacting Protein: Redox Dependent and Independent Regulatory Mechanisms

  2012cited by this paper
• An expanded family of arrestins regulate metabolism.

  2012cited by this paper
• The Role of the NLRP3 Inflammasome in Fibrosis

  2012cited by this paper
• Physiological Relevance of Antioxid/Redox Genes; Learning from Genetically Modified Animals: Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus

  2011cited by this paper
• Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity

  2011cited by this paper
• Inflammasome is a central player in the induction of obesity and insulin resistance

  2011cited by this paper
• A role for mitochondria in NLRP3 inflammasome activation

  2011cited by this paper
• Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling

  2011cited by this paper
• Suppressive effects of YiGanKang, a combination of Chinese herbs, on collagen synthesis in hepatic stellate cell.

  2011cited by this paper
• Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

  2011cited by this paper
• Obesity, insulin resistance and free fatty acids

  2011cited by this paper
• Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells

  2011cited by this paper
• Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver.

  2011cited by this paper
• Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy

  2010cited by this paper
• Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

  2010cited by this paper
• The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance

  2010cited by this paper
• Thioredoxin-interacting protein links oxidative stress to inflammasome activation

  2010cited by this paper
• Thioredoxin-interacting Protein (Txnip) Gene Expression

  2010cited by this paper
• Role of interleukin-1beta during pain and inflammation.

  2009cited by this paper
• Thioredoxin-Binding Protein-2 Deficiency Enhances Methionine-Choline Deficient Diet-Induced Hepatic Steatosis But Inhibits Steatohepatitis in Mice

  2009cited by this paper
• Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions

  2009cited by this paper
• Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

  2009cited by this paper
• Txnip balances metabolic and growth signaling via PTEN disulfide reduction

  2008cited by this paper
• Recent advances in nonalcholic fatty liver disease

  2008cited by this paper
• TXNIP links redox circuitry to glucose control.

  2007cited by this paper
• The Interaction of Thioredoxin with Txnip

  2006cited by this paper
• Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells.

  2006cited by this paper
• Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.

  2005cited by this paper
• Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells*

  2004cited by this paper
• Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.

  2004cited by this paper
• Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells.

  2004cited by this paper
• Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes.

  2003cited by this paper
• Nonalcoholic steatohepatitis: risk factors for liver fibrosis.

  2002cited by this paper
• Interaction between free fatty acids and glucose metabolism

  2002cited by this paper
• Cytokine Receptors and Signaling in Hepatic Stellate Cells

  2001cited by this paper
• Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.

  2000cited by this paper
• The hepatic stellate (Ito) cell: its role in human liver disease

  1997cited by this paper
• In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects.

  1991cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper

• METTL3 inhibits liver fibrosis via RBX1 stability and TXNIP-mediated ferroptosis

  2025cites this paper
• Copper oxide nanoparticles exacerbate chronic obstructive pulmonary disease by activating the TXNIP-NLRP3 signaling pathway

  2024cites this paper
• Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications.

  2024cites this paper
• Anti-obesity effects of chlorogenic acid and caffeine- lipid nanoparticles through PPAR-γ/C/EBP-ɑ pathways

  2023cites this paper
• SGLT-2i: Nanoparticular-Based Strategies, Solutions, and Clinical Applications in Opposition to Low Bioavailability

  2023cites this paper
• A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis

  2023cites this paper
• Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway

  2022cites this paper
• DMSO_A_349153 225..233

  2022influential citation
• Physiological and Pathophysiological Roles of Thioredoxin Interacting Protein: A Perspective on Redox Inflammation and Metabolism

  2022cites this paper
• Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus

  2022influential citation
• Role of Thioredoxin-Interacting Protein in Diabetic Fatty Kidney Induced by Advanced Glycation End-Products.

  2021cites this paper
• IFN-γ contributes to the hepatic inflammation in HFD-induced nonalcoholic steatohepatitis by STAT1β/TLR2 signaling pathway.

  2021cites this paper
• Tebuconazole induces liver injury coupled with ROS-mediated hepatic metabolism disorder.

  2021cites this paper
• Titanium Dioxide Nanoparticles Exacerbate Allergic Airway Inflammation via TXNIP Upregulation in a Mouse Model of Asthma

  2021cites this paper
• Identification of Gm15441, a Txnip antisense lncRNA, as a critical regulator in liver metabolic homeostasis

  2021cites this paper
• Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response

  2021cites this paper
• Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways.

  2020cites this paper
• Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis

  2020cites this paper
• Progress in the mechanism and targeted drug therapy for COPD

  2020cites this paper
• Effects of dietary fibres on gut microbial metabolites and liver lipid metabolism in growing pigs.

  2020cites this paper
• Deletion of Thioredoxin-Interacting Protein (TXNIP) Abrogates High Fat Diet-Induced Retinal Leukostasis, Barrier Dysfunction and Microvascular Degeneration in a Mouse Obesity Model

  2020cites this paper
• Arachidonate 12S-lipoxygenase of platelet-type in hepatic stellate cells of methionine and choline-deficient diet-fed mice.

  2020cites this paper
• Mitigative effects of the bioactive flavonol fisetin on high‐fat/high‐sucrose induced nonalcoholic fatty liver disease in rats

  2019cites this paper
• Anti-Allergic and Anti-Inflammatory Effects and Molecular Mechanisms of Thioredoxin on Respiratory System Diseases

  2019cites this paper
• Taurine Alleviates Schistosoma-Induced Liver Injury by Inhibiting the TXNIP/NLRP3 Inflammasome Signal Pathway and Pyroptosis

  2019cites this paper
• Effect of high-fat diet feeding and associated transcriptome changes in the peak lactation mammary gland in C57BL/6 dams.

  2018cites this paper